Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma

This study has been completed.
Sponsor:
Collaborator:
Bristol-Myers Squibb
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT01409174
First received: August 2, 2011
Last updated: May 10, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2016
  Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)